TIMM13
gene geneOn this page
Also known as Tim13
Summary
TIMM13 (translocase of inner mitochondrial membrane 13, HGNC:11816) is a protein-coding gene on chromosome 19p13.3, encoding Mitochondrial import inner membrane translocase subunit Tim13 (Q9Y5L4). Mitochondrial intermembrane chaperone that participates in the import and insertion of some multi-pass transmembrane proteins into the mitochondrial inner membrane. It is a selective cancer dependency (DepMap: 89.7% of cell lines).
This gene encodes a member of the evolutionarily conserved TIMM (translocase of inner mitochondrial membrane) family of proteins that function as chaperones in the import of proteins from the cytoplasm into the mitochondrial inner membrane. Proteins of this family play a role in collecting substrate proteins from the translocase of the outer mitochondrial membrane (TOM) complex and delivering them to either the sorting and assembly machinery in the outer mitochondrial membrane (SAM) complex or the TIMM22 complex in the inner mitochondrial membrane. The encoded protein and the translocase of mitochondrial inner membrane 8a protein form a 70 kDa complex in the intermembrane space.
Source: NCBI Gene 26517 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 25 total
- Druggable target: yes
- Cancer dependency (DepMap): dependent in 89.7% of screened cell lines
- MANE Select transcript:
NM_012458
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:11816 |
| Approved symbol | TIMM13 |
| Name | translocase of inner mitochondrial membrane 13 |
| Location | 19p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Tim13 |
| Ensembl gene | ENSG00000099800 |
| Ensembl biotype | protein_coding |
| OMIM | 607383 |
| Entrez | 26517 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 11 protein_coding
ENST00000215570, ENST00000591871, ENST00000853530, ENST00000853531, ENST00000853532, ENST00000853533, ENST00000939024, ENST00000939025, ENST00000939026, ENST00000939027, ENST00000939028
RefSeq mRNA: 1 — MANE Select: NM_012458
NM_012458
CCDS: CCDS12089
Canonical transcript exons
ENST00000215570 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000655658 | 2427256 | 2427324 |
| ENSE00001052192 | 2425625 | 2427046 |
| ENSE00001307687 | 2427414 | 2427586 |
Expression profiles
Bgee: expression breadth ubiquitous, 141 present calls, max score 97.96.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 93.0342 / max 402.4467, expressed in 1825 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 178166 | 83.0790 | 1823 |
| 178168 | 9.8399 | 1783 |
| 178167 | 0.1153 | 40 |
Top tissues by expression
141 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 97.96 | gold quality |
| apex of heart | UBERON:0002098 | 97.22 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 97.22 | gold quality |
| right adrenal gland | UBERON:0001233 | 96.94 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 96.81 | gold quality |
| left adrenal gland | UBERON:0001234 | 96.79 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 96.71 | gold quality |
| right lobe of liver | UBERON:0001114 | 96.20 | gold quality |
| prefrontal cortex | UBERON:0000451 | 96.09 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 96.07 | gold quality |
| esophagus mucosa | UBERON:0002469 | 95.94 | gold quality |
| body of pancreas | UBERON:0001150 | 95.87 | gold quality |
| cortex of kidney | UBERON:0001225 | 95.82 | gold quality |
| metanephros cortex | UBERON:0010533 | 95.57 | gold quality |
| adrenal gland | UBERON:0002369 | 95.44 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 95.43 | gold quality |
| heart left ventricle | UBERON:0002084 | 95.09 | gold quality |
| transverse colon | UBERON:0001157 | 94.97 | gold quality |
| body of stomach | UBERON:0001161 | 94.95 | gold quality |
| frontal cortex | UBERON:0001870 | 94.89 | gold quality |
| frontal lobe | UBERON:0016525 | 94.89 | gold quality |
| substantia nigra | UBERON:0002038 | 94.87 | gold quality |
| skin of abdomen | UBERON:0001416 | 94.83 | gold quality |
| gastrocnemius | UBERON:0001388 | 94.76 | gold quality |
| skin of leg | UBERON:0001511 | 94.63 | gold quality |
| right atrium auricular region | UBERON:0006631 | 94.63 | gold quality |
| zone of skin | UBERON:0000014 | 94.51 | gold quality |
| muscle of leg | UBERON:0001383 | 94.49 | gold quality |
| muscle organ | UBERON:0001630 | 94.35 | gold quality |
| temporal lobe | UBERON:0001871 | 94.32 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-4 | yes | 138.35 |
| E-CURD-122 | yes | 20.20 |
| E-ANND-3 | yes | 14.95 |
| E-MTAB-6075 | no | 329.02 |
| E-MTAB-7249 | no | 190.36 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
38 targeting TIMM13, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-3065-3P | 99.87 | 70.25 | 1407 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-3180-5P | 99.82 | 69.12 | 2422 |
| HSA-MIR-4713-5P | 99.78 | 67.80 | 1794 |
| HSA-MIR-6764-5P | 99.75 | 67.89 | 2304 |
| HSA-MIR-4690-5P | 99.65 | 66.24 | 813 |
| HSA-MIR-1249-5P | 99.61 | 66.55 | 2049 |
| HSA-MIR-6797-5P | 99.61 | 66.55 | 2084 |
| HSA-MIR-1915-3P | 99.58 | 66.79 | 1988 |
| HSA-MIR-6733-3P | 99.54 | 67.80 | 1281 |
| HSA-MIR-4489 | 99.50 | 65.56 | 785 |
| HSA-MIR-330-3P | 99.41 | 69.95 | 2521 |
| HSA-MIR-4796-5P | 99.34 | 70.06 | 810 |
| HSA-MIR-488-5P | 99.28 | 68.12 | 821 |
| HSA-MIR-485-5P | 99.10 | 64.78 | 1889 |
| HSA-MIR-6884-5P | 99.10 | 64.50 | 1987 |
| HSA-MIR-4651 | 99.06 | 67.57 | 2002 |
| HSA-MIR-608 | 98.93 | 67.83 | 2013 |
| HSA-MIR-6829-5P | 98.86 | 65.12 | 1480 |
| HSA-MIR-760 | 98.81 | 66.65 | 1392 |
| HSA-MIR-6840-3P | 98.68 | 65.95 | 1923 |
| HSA-MIR-7977 | 98.65 | 66.18 | 2590 |
| HSA-MIR-4726-3P | 98.49 | 63.89 | 1385 |
| HSA-MIR-483-3P | 97.77 | 64.95 | 731 |
| HSA-MIR-3652 | 97.71 | 65.43 | 1890 |
| HSA-MIR-6783-5P | 97.67 | 67.21 | 1528 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 89.7% of screened cell lines.
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | timm13 | ENSDARG00000058297 |
| mus_musculus | Timm13 | ENSMUSG00000020219 |
| rattus_norvegicus | Timm13 | ENSRNOG00000019682 |
| drosophila_melanogaster | Tim13 | FBGN0036204 |
| drosophila_melanogaster | CG34132 | FBGN0083968 |
| drosophila_melanogaster | CG42302 | FBGN0259198 |
| caenorhabditis_elegans | tin-13 | WBGENE00006574 |
Protein
Protein identifiers
Mitochondrial import inner membrane translocase subunit Tim13 — Q9Y5L4 (reviewed: Q9Y5L4)
All UniProt accessions (2): Q9Y5L4, K7EIT2
UniProt curated annotations — full annotation on UniProt →
Function. Mitochondrial intermembrane chaperone that participates in the import and insertion of some multi-pass transmembrane proteins into the mitochondrial inner membrane. Also required for the transfer of beta-barrel precursors from the TOM complex to the sorting and assembly machinery (SAM complex) of the outer membrane. Acts as a chaperone-like protein that protects the hydrophobic precursors from aggregation and guide them through the mitochondrial intermembrane space. The TIMM8-TIMM13 complex mediates the import of proteins such as TIMM23, SLC25A12/ARALAR1 and SLC25A13/ARALAR2, while the predominant TIMM9-TIMM10 70 kDa complex mediates the import of much more proteins.
Subunit / interactions. Heterohexamer; composed of 3 copies of TIMM8 (TIMM8A or TIMM8B) and 3 copies of TIMM13, named soluble 70 kDa complex. Associates with the TIM22 complex, whose core is composed of TIMM22.
Subcellular location. Mitochondrion inner membrane.
Tissue specificity. Ubiquitous, with highest expression in heart, kidney, liver and skeletal muscle.
Domain organisation. The twin CX3C motif contains 4 conserved Cys residues that form 2 disulfide bonds in the mitochondrial intermembrane space. However, during the transit of TIMM13 from cytoplasm into mitochondrion, the Cys residues probably coordinate zinc, thereby preventing folding and allowing its transfer across mitochondrial outer membrane.
Similarity. Belongs to the small Tim family.
RefSeq proteins (1): NP_036590* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004217 | Tim10-like | Domain |
| IPR035427 | Tim10-like_dom_sf | Homologous_superfamily |
Pfam: PF02953
UniProt features (10 total): modified residue 3, sequence conflict 3, disulfide bond 2, chain 1, short sequence motif 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y5L4-F1 | 85.14 | 0.61 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 1, 7, 53
Disulfide bonds (2): 46–69, 50–65
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-1268020 | Mitochondrial protein import |
MSigDB gene sets: 139 (showing top):
GOBP_SENSORY_PERCEPTION_OF_MECHANICAL_STIMULUS, GOBP_PROTEIN_TARGETING, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE, GOCC_MITOCHONDRIAL_ENVELOPE, TIEN_INTESTINE_PROBIOTICS_24HR_UP, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_SENSORY_PERCEPTION, WONG_MITOCHONDRIA_GENE_MODULE, GOBP_MEMBRANE_ORGANIZATION, GOBP_PROTEIN_LOCALIZATION_TO_MITOCHONDRION, GOBP_PROTEIN_TARGETING_TO_MITOCHONDRION, GOBP_LOCALIZATION_WITHIN_MEMBRANE, CUI_TCF21_TARGETS_2_UP
GO Biological Process (4): obsolete protein targeting to mitochondrion (GO:0006626), sensory perception of sound (GO:0007605), protein transport (GO:0015031), protein insertion into mitochondrial inner membrane (GO:0045039)
GO Molecular Function (3): zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (6): fibrillar center (GO:0001650), mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial intermembrane space (GO:0005758), mitochondrial intermembrane space chaperone complex (GO:0042719), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Protein localization | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| sensory perception of mechanical stimulus | 1 |
| transport | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| inner mitochondrial membrane organization | 1 |
| mitochondrial protein import pathway | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| nucleolus | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| mitochondrial envelope | 1 |
| organelle envelope lumen | 1 |
| mitochondrial intermembrane space | 1 |
| mitochondrial protein-containing complex | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
148 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MAP3K14 | CHUK | psi-mi:“MI:0914”(association) | 0.950 |
| AFG2B | AFG2A | psi-mi:“MI:0914”(association) | 0.800 |
| EZR | MSN | psi-mi:“MI:0914”(association) | 0.740 |
| TIMM8A | TIMM13 | psi-mi:“MI:0915”(physical association) | 0.740 |
| TIMM8A | TIMM13 | psi-mi:“MI:0407”(direct interaction) | 0.740 |
| CHCHD4 | SSNA1 | psi-mi:“MI:0914”(association) | 0.640 |
| CCDC120 | AIP | psi-mi:“MI:0914”(association) | 0.640 |
| LLGL1 | DNAJA2 | psi-mi:“MI:0914”(association) | 0.640 |
| USHBP1 | TIMM13 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PDYN | ACAD11 | psi-mi:“MI:0914”(association) | 0.530 |
| YBEY | NME4 | psi-mi:“MI:0914”(association) | 0.530 |
| HSF4 | HSF1 | psi-mi:“MI:0914”(association) | 0.530 |
| env | PGRMC1 | psi-mi:“MI:0914”(association) | 0.460 |
| AIFM1 | HAX1 | psi-mi:“MI:0914”(association) | 0.420 |
| AIFM1 | HAX1 | psi-mi:“MI:2364”(proximity) | 0.420 |
| HTRA2 | HAX1 | psi-mi:“MI:2364”(proximity) | 0.420 |
| MAPT | TIMM13 | psi-mi:“MI:2364”(proximity) | 0.420 |
| ADRM1 | TIMM13 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CDC34 | TIMM13 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TIMM13 | KLF11 | psi-mi:“MI:0915”(physical association) | 0.370 |
| YWHAZ | WDR62 | psi-mi:“MI:0914”(association) | 0.350 |
| MYO1C | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 |
| MATR3 | BCLAF3 | psi-mi:“MI:0914”(association) | 0.350 |
| DBN1 | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 |
| TUBG1 | DPM1 | psi-mi:“MI:0914”(association) | 0.350 |
| GPATCH8 | FDX1 | psi-mi:“MI:0914”(association) | 0.350 |
| Myo1c | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 |
| Kif3c | ARPC1B | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (218): TIMM13 (Affinity Capture-MS), TIMM13 (Affinity Capture-MS), MIF (Co-fractionation), NDRG1 (Co-fractionation), TIMM10 (Co-fractionation), TIMM13 (Co-fractionation), TIMM13 (Co-fractionation), TIMM13 (Co-fractionation), TIMM8A (Co-fractionation), TIMM8B (Co-fractionation), TIMM13 (Affinity Capture-MS), ALB (Affinity Capture-MS), BPTF (Affinity Capture-MS), BCL7C (Affinity Capture-MS), VPRBP (Affinity Capture-MS)
ESM2 similar proteins: A4QNC6, B0BN94, O74700, P0CR96, P0CR97, P0CS00, P0CS01, P30629, P62075, P62076, P62077, P62078, Q10481, Q2HJI3, Q2KIV2, Q3SZ93, Q4I6B0, Q4V7R1, Q59MI8, Q59R24, Q5ZIR8, Q616Q2, Q61TH2, Q63ZH8, Q66L32, Q6BN23, Q6BU42, Q6CM57, Q6DEM5, Q6DGJ3, Q6FK81, Q6GPY0, Q6PBU0, Q75DU7, Q7SBR3, Q8AVK1, Q90YI5, Q96C01, Q9CR98, Q9N408
Diamond homologs: O45319, P0CS00, P0CS01, P53299, P62075, P62076, Q10481, Q4I6B0, Q4PGT2, Q4X0V2, Q5AF54, Q5AZH4, Q6CJX3, Q6DGJ3, Q6FRE1, Q6GPY0, Q75F72, Q8AVK1, Q9VTN3, Q9XGY5, Q9Y193, Q9Y5L4, O60220, P0CR94, P0CR95, P57744, P62077, P62078, Q3SZ93, Q3ZBS8, Q4FZG7, Q59MI8, Q616Q2, Q66L32, Q6BN23, Q6CWH5, Q6DEM5, Q6FK81, Q75DU7, Q90YI5
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 180 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Activation of NF-kappaB in B cells | 6 | 9.8× | 6e-03 |
| CLEC7A (Dectin-1) signaling | 8 | 9.5× | 1e-03 |
| FCERI mediated NF-kB activation | 7 | 9.1× | 3e-03 |
| Mitochondrial protein degradation | 8 | 7.6× | 3e-03 |
| Downstream TCR signaling | 7 | 7.5× | 6e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
25 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 23 |
| Likely benign | 0 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
314 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:2427042:CACTT:C | acceptor_gain | 1.0000 |
| 19:2427044:CTT:C | acceptor_gain | 1.0000 |
| 19:2427045:TT:T | acceptor_gain | 1.0000 |
| 19:2427046:TC:T | acceptor_loss | 1.0000 |
| 19:2427047:C:CC | acceptor_gain | 1.0000 |
| 19:2427047:CTGC:C | acceptor_loss | 1.0000 |
| 19:2427251:CTCA:C | donor_loss | 1.0000 |
| 19:2427252:TCACC:T | donor_loss | 1.0000 |
| 19:2427253:CACCT:C | donor_loss | 1.0000 |
| 19:2427255:C:A | donor_loss | 1.0000 |
| 19:2427321:TCCT:T | acceptor_gain | 1.0000 |
| 19:2427322:CCTC:C | acceptor_gain | 1.0000 |
| 19:2427323:CT:C | acceptor_gain | 1.0000 |
| 19:2427325:C:CC | acceptor_gain | 1.0000 |
| 19:2427408:CCGCA:C | donor_loss | 1.0000 |
| 19:2427409:CGCAC:C | donor_loss | 1.0000 |
| 19:2427411:CACC:C | donor_loss | 1.0000 |
| 19:2425922:AACAG:A | acceptor_gain | 0.9900 |
| 19:2425925:AG:A | acceptor_gain | 0.9900 |
| 19:2425926:GG:G | acceptor_gain | 0.9900 |
| 19:2427255:CCTG:C | donor_gain | 0.9900 |
| 19:2427320:ATCCT:A | acceptor_gain | 0.9900 |
| 19:2427322:CCTCT:C | acceptor_loss | 0.9900 |
| 19:2427324:TC:T | acceptor_loss | 0.9900 |
| 19:2425921:CAACA:C | acceptor_loss | 0.9800 |
| 19:2425924:CA:C | acceptor_loss | 0.9800 |
| 19:2425925:A:G | acceptor_loss | 0.9800 |
| 19:2425926:G:GA | acceptor_loss | 0.9800 |
| 19:2425926:GGGT:G | acceptor_gain | 0.9800 |
| 19:2427056:C:CT | acceptor_gain | 0.9800 |
AlphaMissense
628 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:2426995:A:G | S81P | 1.000 |
| 19:2427010:C:G | A76P | 1.000 |
| 19:2427021:C:G | R72P | 1.000 |
| 19:2427030:C:T | C69Y | 1.000 |
| 19:2427297:A:G | C50R | 1.000 |
| 19:2427307:A:C | C46W | 1.000 |
| 19:2427308:C:A | C46F | 1.000 |
| 19:2427308:C:T | C46Y | 1.000 |
| 19:2427309:A:G | C46R | 1.000 |
| 19:2427431:C:G | A35P | 1.000 |
| 19:2427437:C:G | A33P | 1.000 |
| 19:2427443:C:G | A31P | 1.000 |
| 19:2426989:C:G | A83P | 0.999 |
| 19:2426997:A:T | V80E | 0.999 |
| 19:2427009:G:T | A76D | 0.999 |
| 19:2427022:G:T | R72S | 0.999 |
| 19:2427025:C:G | D71H | 0.999 |
| 19:2427029:G:C | C69W | 0.999 |
| 19:2427030:C:A | C69F | 0.999 |
| 19:2427031:A:G | C69R | 0.999 |
| 19:2427037:C:G | A67P | 0.999 |
| 19:2427041:G:C | C65W | 0.999 |
| 19:2427042:C:G | C65S | 0.999 |
| 19:2427042:C:T | C65Y | 0.999 |
| 19:2427043:A:G | C65R | 0.999 |
| 19:2427043:A:T | C65S | 0.999 |
| 19:2427295:A:C | C50W | 0.999 |
| 19:2427296:C:A | C50F | 0.999 |
| 19:2427296:C:G | C50S | 0.999 |
| 19:2427296:C:T | C50Y | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000223929 (19:2429542 G>A), RS1000857314 (19:2427309 A>C), RS1002500540 (19:2426291 G>A,C), RS1002516479 (19:2429450 G>A), RS1002591426 (19:2429574 C>T), RS1002743096 (19:2425568 C>A,G,T), RS1003102569 (19:2425749 G>A,C), RS1003521548 (19:2427997 GA>G,GAA), RS1004210887 (19:2425472 G>A,C), RS1005208420 (19:2425975 G>A,C), RS1005538231 (19:2426551 T>C), RS1005714531 (19:2425737 G>A,C,T), RS1006309620 (19:2426616 G>A), RS1006547208 (19:2425820 G>A), RS1006627162 (19:2426798 C>A,T)
Disease associations
OMIM: gene MIM:607383 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6066276 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
39 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, increases methylation, affects cotreatment | 3 |
| Tretinoin | decreases expression | 2 |
| terbufos | increases methylation | 1 |
| sodium arsenite | decreases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| ochratoxin A | decreases expression | 1 |
| pinosylvin | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| corosolic acid | decreases expression | 1 |
| K 7174 | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | decreases expression, affects cotreatment | 1 |
| abrine | decreases expression | 1 |
| LDN 193189 | affects cotreatment, decreases expression | 1 |
| NSC 689534 | affects binding, decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Amiodarone | increases expression | 1 |
| Arsenic | decreases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Copper | affects binding, decreases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Fonofos | increases methylation | 1 |
| Ethyl Methanesulfonate | decreases expression | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Parathion | increases methylation | 1 |
| Piroxicam | affects cotreatment, decreases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5652630 | Binding | Binding affinity to human TIMM13 incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.